 |
Janssen Pharmaceutica Products, LP, a leading provider of healthcare products and services, has entered into a co-promotion agreement with Japanese pharmaceutical giant Eisai Inc. for Eisai's Aciphex brand. Janssen is responsible for developing direct-to-consumer acquisition and patient retention programs to market Aciphex (a Proton Pump Inhibitor used in the treatment of Acid Reflux Disease) in the U.S.
|
|
|
|
